Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
OCULAR THERAPEUTIX, INC | Director | Common Stock | 36K | $210K | $5.84 | Jul 24, 2024 | Direct |
Ocuphire Pharma, Inc. | Director | Stock Option (right to buy) | 173K | Oct 22, 2024 | Direct | ||
OCULAR THERAPEUTIX, INC | Director | Stock Option (Right to Buy) | 36K | Jul 24, 2024 | Direct | ||
HARROW, INC. | Director | RSU | 8.35K | Jun 14, 2024 | Direct | ||
IVERIC bio, Inc. | Director | Common Stock | 0 | $39.45 | Jul 11, 2023 | Direct | |
IVERIC bio, Inc. | Director | Restricted Stock Units | 0 | Jul 11, 2023 | Direct | ||
IVERIC bio, Inc. | Director | Stock Option (Right to Buy) | 0 | $10.03 | Jul 11, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IRD | Opus Genetics, Inc. | Oct 22, 2024 | 1 | $0 | 4 | Oct 24, 2024 | Director |
IRD | Opus Genetics, Inc. | Oct 22, 2024 | 0 | $0 | 3 | Oct 24, 2024 | Director |
OCUL | OCULAR THERAPEUTIX, INC | Jul 24, 2024 | 2 | $0 | 4 | Jul 26, 2024 | Director |
HROW | HARROW, INC. | Jun 14, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
HROW | HARROW, INC. | Jan 26, 2024 | 1 | $0 | 4 | Jan 30, 2024 | Director |
HROW | HARROW, INC. | Jan 26, 2024 | 0 | $0 | 3 | Jan 30, 2024 | Director |
ISEE | IVERIC bio, Inc. | Jul 11, 2023 | 7 | $0 | 4 | Jul 13, 2023 | Director |
OCUL | OCULAR THERAPEUTIX, INC | Jul 10, 2023 | 2 | $0 | 4 | Jul 12, 2023 | Director |
OCUL | OCULAR THERAPEUTIX, INC | Jul 10, 2023 | 0 | $0 | 3 | Jul 12, 2023 | Director |
ISEE | IVERIC bio, Inc. | May 17, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
ISEE | IVERIC bio, Inc. | May 11, 2023 | 2 | $0 | 4 | May 15, 2023 | Director |
ISEE | IVERIC bio, Inc. | May 11, 2022 | 4 | $0 | 4 | May 13, 2022 | Director |
ISEE | IVERIC bio, Inc. | May 19, 2021 | 2 | $0 | 4 | May 20, 2021 | Director |